4
Changes in Ownership
Cocrystal Pharma, Inc. Filed Acc 0001493152-18-006784
Director acquired 263,158 shares (option exercise)
- Director acquired 10,209 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schinazi Raymond F Director | 2018-05-10 | Option exercise | +263,158 | $1.90 | $500,000 | 985,384 | I |
| Schinazi Raymond F Director | 2018-05-10 | Grant or award | +10,209 | $1.90 | $19,397 | 995,593 | I |
| Derivatives | |||||||
| Schinazi Raymond F Director | 2018-05-10 | Returned to the company · 8% Convertible Note | −61,728 | $500,000.00 | $30,864,000,000 | 61,728 | I |
| Schinazi Raymond F Director | 2018-05-10 | Grant or award · 8% Convertible Note | +263,158 | $500,000.00 | $131,579,000,000 | 263,158 | I |
| Schinazi Raymond F Director | 2018-05-10 | Option exercise · 8% Convertible Note | −263,158 | $500,000.00 | $131,579,000,000 | 263,158 | I |
Loading xslF345X03/form4.xml…